Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants
Tonke Van Bragt, Jan Noukens, Shan Jing, Pu Xia et al.
Citations
1 citations
Journal
Drugs in R&D
Topics
Toxin Mechanisms and Immunotoxins
Field-Weighted Citation Impact (FWCI)
0.24
article
Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants
Tonke Van Bragt, Jan Noukens, Shan Jing, Pu Xia, Harald H. Reinhart, Lina Wang, Xiaowen Gu, Jiajia Chen, Yu Zhang, Yang Lin, Antonio Guglietta, Jing Liu
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Drugs in R&DVol. 24(4)
Institutions
Capital Medical University (CN), Thales (Netherlands) (NL), Zapata (United States) (US), Beijing Anzhen Hospital (CN), Wuhan Union Hospital (CN), Argenx (Belgium) (BE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants — Tonke Van Bragt, Jan Noukens, et al. · Drugs in R&D (2024) | TGRS Research Map | TGRS